|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
113,340,000 |
Market
Cap: |
128.64(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.6758 - $2.59 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
41,140 |
41,140 |
Total Buy Value |
$0 |
$0 |
$49,985 |
$49,985 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
251,186 |
267,139 |
312,283 |
979,563 |
Total Sell Value |
$297,360 |
$316,630 |
$384,544 |
$4,272,335 |
Total People Sold |
6 |
6 |
6 |
8 |
Total Sell Transactions |
18 |
22 |
34 |
59 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shacham Sharon |
President & CSO |
|
2018-10-08 |
4 |
AS |
$15.39 |
$196,832 |
D/D |
(12,500) |
713,510 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-10-08 |
4 |
OE |
$0.03 |
$413 |
D/D |
12,500 |
726,010 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-10-08 |
4 |
AS |
$15.39 |
$196,832 |
I/I |
(12,500) |
713,510 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-10-08 |
4 |
OE |
$0.03 |
$413 |
I/I |
12,500 |
726,010 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-09-18 |
4 |
AS |
$18.26 |
$182,615 |
I/I |
(10,000) |
512,143 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-09-18 |
4 |
OE |
$4.75 |
$47,520 |
I/I |
10,000 |
522,143 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-09-18 |
4 |
AS |
$18.26 |
$182,615 |
D/D |
(10,000) |
512,143 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-09-18 |
4 |
OE |
$4.75 |
$47,520 |
D/D |
10,000 |
522,143 |
|
- |
|
Primiano Christopher Brett |
EVP, CBO, GC & Secretary |
|
2018-09-10 |
4 |
AS |
$18.90 |
$189,046 |
D/D |
(10,000) |
2,881 |
|
- |
|
Primiano Christopher Brett |
EVP, CBO, GC & Secretary |
|
2018-09-10 |
4 |
OE |
$6.54 |
$84,650 |
D/D |
10,000 |
12,881 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-09-07 |
4 |
AS |
$19.31 |
$241,384 |
I/I |
(12,500) |
713,510 |
|
- |
|
Kauffman Michael |
Chief Executive Officer |
|
2018-09-07 |
4 |
OE |
$0.03 |
$413 |
I/I |
12,500 |
726,010 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-09-07 |
4 |
AS |
$19.31 |
$241,384 |
D/D |
(12,500) |
713,510 |
|
- |
|
Shacham Sharon |
President & CSO |
|
2018-09-07 |
4 |
OE |
$0.03 |
$413 |
D/D |
12,500 |
726,010 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2018-09-06 |
4 |
S |
$20.52 |
$98,474 |
D/D |
(4,800) |
7,631,267 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2018-09-05 |
4 |
S |
$21.06 |
$3,370,256 |
D/D |
(160,000) |
7,636,067 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2018-09-04 |
4 |
S |
$20.60 |
$824,072 |
D/D |
(40,000) |
7,796,067 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2018-08-31 |
4 |
S |
$21.05 |
$241,396 |
D/D |
(11,468) |
7,836,067 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2018-08-30 |
4 |
AS |
$21.00 |
$52,500 |
D/D |
(2,500) |
0 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2018-08-30 |
4 |
OE |
$1.49 |
$4,810 |
D/D |
2,500 |
264 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2018-08-30 |
4 |
S |
$21.00 |
$4,199,900 |
D/D |
(200,000) |
7,847,535 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2018-08-29 |
4 |
AS |
$20.00 |
$50,000 |
D/D |
(2,500) |
0 |
|
- |
|
Mirza Mansoor Raza |
Director |
|
2018-08-29 |
4 |
OE |
$1.49 |
$3,713 |
D/D |
2,500 |
2,500 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2018-08-29 |
4 |
S |
$19.59 |
$3,918,280 |
D/D |
(200,000) |
8,047,535 |
|
- |
|
Smolokowski Wiaczeslaw |
10% Owner |
|
2018-08-27 |
4 |
S |
$18.52 |
$259,776 |
D/D |
(14,026) |
8,247,535 |
|
- |
|
592 Records found
|
|
Page 15 of 24 |
|
|